The Nollywoood Actress, Halima Abubakar, has taken to social media to dish out her two cents to fans after her reappearance on social media.
The actress had been diagnosed of Lupus which is an ailment whereby the immune system attacks the tissues and organs of the body. This had made her stay off from social media for a period of time, following the controversies of the source of her ailment.
Halima took to her verified Instagram page on the 13th of March 2023, to appreciate her fans and the public for the prayers, encouragement and love she received during her trying time, assuring them of her new path and life.
She further dished advice to women to ensure they find a business to venture into rather than chasing married men.
See Screenshot below:
Fans of the actress took their time to pray and celebrate their favourite's recovery.
See screenshot below:
Content created and supplied by: AdesolaJoseph949 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More